Improper regulation of translation initiation, a vital check-point of protein synthesis in the cell, has been linked to a number of cancers. Overexpression of protein subunits of eukaryotic translation initiation factor 3 (eIF3) has been associated with increased translation of mRNAs involved in cell proliferation. In addition to playing a major role in general translation initiation by serving as a scaffold for the assembly of translation initiation complexes, eIF3 regulates translation of specific cellular mRNAs and viral RNAs. 
Introduction
Eukaryotic translation initiation is tightly controlled and its deregulation can lead to a wide variety of disorders, including cancer (1). During canonical translation initiation, the eukaryotic small (40S) ribosomal subunit first associates with initiation factors eIF1, eIF1A, eIF3, and eIF5, and is subsequently loaded with the eIF2 ternary complex (eIF2-GTP-Met-tRNA Met i ).
It then binds to the mRNA-bearing eIF4F complex (EIF4A, 4B, 4G, 4E) to begin directional scanning of the 5' untranslated region (5'-UTR) for the start codon (2) . Distinct from the canonical scanning mechanism, recent evidence indicates that eIF3-the largest of the translation initiation factors comprised of 13 subunits (EIF3A-M) in mammals-regulates alternative pathways of translation initiation. For select cellular mRNAs, eIF3 can either activate or repress translation by interacting with RNA structural elements in the 5'-UTRs of these mRNAs (3).
Additionally, eIF3 can bind the 5'-cap of mRNAs using EIF3D (4), allowing translation of select transcripts to continue under cellular stress conditions when eIF4E is inactivated. Finally, eIF3
can also promote translation under stress conditions by binding m 6 A-methylated 5'-UTRs in a cap-independent manner (5, 6) . In all these cases, the molecular basis for eIF3-dependent translation regulation and its control of gene expression networks remain unclear.
Structural analysis using cryo-electron microscopy (cryo-EM) revealed that the core of eIF3, a five-lobed octameric complex, localizes to the solvent-exposed "backside" of the 40S subunit and spans the mRNA entry and exit channels (7) . In the mammalian 43S pre-initiation complex (PIC), eIF3 subunits EIF3A and EIF3C directly contact the 40S subunit (8) , as well as participate in interactions with eIF1, eIF1A, eIF2, eIF5, and eIF4F (9, 10) , thus coordinating the ordered assembly of the 48S initiation complex. By contrast with canonical initiation, translation of the Hepatitis C Virus (HCV) genomic RNA requires an Internal Ribosome Entry Site (HCV IRES) RNA structure in the 5'-UTR, which binds to subunits EIF3A and EIF3C within the eIF3 complex (11) . Recent cryo-EM structures revealed how an HCV-like viral IRES displaces eIF3 from binding the 40S subunit, while still binding to eIF3 through subunits EIF3A and EIF3C (12) ( Fig. 1A) . The importance of the EIF3A subunit in mediating RNA binding is underscored by in vitro translation (IVT) experiments in which mutation of amino acids 36-39 (KSKK > NSEE) in a predicted RNA-binding HLH (Helix-Loop-Helix) motif abrogated eIF3 binding to the HCV IRES (11) . While these experiments indicated that the HLH motif of EIF3A is critical for mediating HCV IRES binding by eIF3, the importance of this motif for cellular mRNA translation remains to be determined.
Beyond the role of EIF3D in binding the mRNA m 7 G cap (4), the mechanisms responsible for eIF3-mediated regulation of specific cellular mRNAs remain unclear. Structural models for eIF3 bound to 43S and 48S pre-initiation complexes suggest that eIF3 controls the translation of the HCV IRES in a distinct manner compared to cellular transcripts, whether involving canonical scanning or eIF3-dependent regulation of specific transcripts. In addition to its displacement from the 40S subunit by the HCV IRES RNA in the cryo-EM reconstruction, the HLH motif in EIF3A is spatially distant from the EIF3D cap-binding domain (10) and is more discrete than the proposed multi-subunit interface thought to recognize specific RNA secondary structures (3) and m 6 A modifications (5, 13) . We therefore probed the role of the EIF3A HLH motif in regulating cellular translation initiation in cells and in vitro. We found that mutations in the EIF3A HLH motif affected the translational efficiency of transcripts involved in proliferative pathways, including the mRNAs encoding MYC, PRL3 and MET. MYC is a well-known transcription factor strongly associated with cancer initiation and is found to be deregulated in over half of human cancers, whereas PRL3 and MET are implicated in cancer metastasis through regulating oncogenic effector pathways, such as PI3K/Akt/mTOR and HGF/SF signaling, respectively (14) (15) (16) . The selective enhancement of translation initiation on cancer-associated transcripts by the EIF3A HLH motif highlights a new mode of eIF3 translation regulation and identifies a welldefined, discrete structural motif (13) that could be targeted for future drug development efforts.
Results

Mutation of the EIF3A HLH motif causes selective translation repression of proliferative mRNAs
We first introduced a 3 amino-acid mutation in the HLH RNA-binding motif in EIF3A
(KSKK > NSEE, hereafter termed EIF3A HLH*), previously shown to disrupt HCV IRESmediated translation initiation (11) , into HEK293T cells using a lentiviral delivery and integration system under hygromycin selection. We then knocked down endogenous EIF3A expression using an shRNA targeting the native mRNA 3'-UTR, expressed by a second lentiviral system under dual hygromycin/puromycin selection (table S1) . We also generated control (CT) cell lines in the same manner but with no mutation in the exogenous EIF3A sequence. HLH* cell lysates showed a dramatic (~80%) decrease in encephalomyocarditis virus (EMCV) IRES-mediated translation, consistent with the effects previously seen in vitro with reconstituted eIF3 and the HCV IRES (Fig. 1B) (11) .
We then used the CT and HLH* cell lines to determine the effect of the EIF3A HLH mutation on the translational efficiency of cellular mRNAs. To assess the extent of mutant EIF3A expression, RNA deep sequencing (RNAseq) data were aligned to wild-type and HLH* EIF3A sequences, revealing that >80% of aligned HLH reads mapped to the HLH* sequence, and confirming robust expression of exogenous over endogenous EIF3A (Fig. 1C) . At the transcriptional level, HLH* EIF3A had little effect on mRNA expression ( fig. S1 ). However, bioinformatic analysis of ribosome profiling data, normalized to the RNAseq data, revealed a small number of transcripts differentially regulated at the translational level in cells expressing HLH* EIF3A, 80 negatively regulated and 25 positively regulated (p<0.01 and >3x change, Fig.   1D , fig. S2A ). Functional classification of these genes showed strong enrichment of oncogenic transcripts ( Fig. 1E) , including those encoding PRL3, MYC and MET, all of which were negatively affected by HLH* EIF3A (Fig. 1D) . Consistent with the ribosome profiling results,
Western blot analysis showed a decrease in protein levels for MYC, MET, and PRL3 (Fig. 1F) .
Notably, in experiments using transient expression of HLH* EIF3A, MYC protein levels were also suppressed at 72 hours post-transfection, when transcript levels for the mRNA encoding HLH* EIF3A dropped to less than 50% of wild-type EIF3A mRNA levels ( fig. S1A ). Taken together, these results indicate that HLH* EIF3A lowers the translation of certain oncogenic transcripts such as MYC that are important for cell proliferation, in a dominant negative manner.
In longer timeframes than those used to collect samples for the ribosome profiling and
RNAseq experiments, we observed that the shRNA cell lines expressing HLH* EIF3A had reverted MYC protein expression to those seen in CT cells, and proliferated like CT cells with increased passage number. We therefore engineered HEK293T cells to express CT or HLH* EIF3A from transducted lentiviral vectors, as in the shRNA cell lines, but instead using CRISPRi to suppress expression of endogenous EIF3A (table S1 ). In the CRISPRi cell lines, we observed the same decrease in MYC, MET, and PRL3 levels by Western blot as in the shRNA cell lines (Fig. 1G) . Although the CRISPRi cell lines exhibited a moderate global decrease in translation, in contrast to the shRNA-based cell lines as determined by metabolic labeling ( fig. S1B ), we continued to use the CRISPRi cell lines for subsequent biochemical and luciferase reporter-based experiments since they were more stable with passage number compared to the shRNA cell lines, as assessed by growth rate and relative MYC levels as a function of passage number.
HLH* EIF3A causes transcript-specific defects in translation initiation factor recruitment
To test the effect of HLH* EIF3A on translation initiation, we used the CRISPRi-based CT and HLH* cell lines to prepare cytoplasmic extracts for in vitro translation experiments. We programmed these extracts with full-length GAPDH and MYC mRNAs, and stalled translation reactions with either cycloheximide or GMPPNP, and fractionated them on sucrose gradients (Fig. 2, A and B) . Cycloheximide stalls 80S ribosomes immediately after initiation, whereas GMPPNP stalls 48S pre-initiation complexes at the start codon (11, 17) . In Western blots of the sucrose gradient fractions, we observed a defect in EIF3A and EIF5B distribution in the HLH* EIF3A in vitro translation reactions programmed with either GAPDH or MYC mRNA (Fig. 2, C -F ). These results are consistent with those using reconstituted eIF3 and the HCV IRES, which
showed that the EIF3A HLH motif is important for eIF3 association with the 40S subunit, and for EIF5B association with pre-initiation complexes and the 80S ribosome (11) , and suggest these defects are general. We did not observe a defect in the distribution of Met-tRNA i in contrast to the previously observed Met-tRNA i distribution defect in in vitro reconstituted HCV IRES mediated translation with reconstituted eIF3 (11) ( fig. S3A-C) . Notably, in vitro translation reactions using HLH* EIF3A extracts programmed with MYC mRNA exhibited a specific defect in EIF4A1 incorporation into preinitiation complexes (Fig. 2, E and F) . The defect in EIF4A1 distribution occurred in both cycloheximide and GMPPNP stalled reactions, suggesting that HLH* EIF3A selectively destabilizes 48S pre-initiation complexes on some mRNAs (Fig. 2, fig. S4A ).
HLH* EIF3A sensitizes translation extracts to eIF4A1 inhibitor RocA
To address the destabilizing effect of HLH* EIF3A on EIF4A1 incorporation into 48S
pre-initiation complexes, we used Rocaglamide A (RocA) to inhibit EIF4A1 function in CT and HLH* extracts. RocA causes stalling, premature upstream initiation, and decreased translation by locking EIF4A1 onto poly-purine sequences in the 5'-UTR of mRNAs (18) . In vitro translation of Renilla luciferase reporter mRNAs harboring the HCV IRES or MYC 5'-UTR showed a marked translation defect in extracts from the HLH* cells (Fig. 3A) . By contrast, a Firefly luciferase reporter mRNA with the HBB 5'-UTR used as a control was unaffected by HLH* EIF3A, indicating that the HLH* mutation is specific to EIF3A HLH-sensitive mRNAs in a 5'-UTR dependent manner (Fig. 3A) . Notably, HLH* EIF3A further sensitizes the HCV IRES and the MYC 5'-UTR to RocA in the in vitro translation reactions (Fig. 3B) . The RocA-dependent decrease in translation occurred in addition to the HLH*-specific defect (Fig. 3A) . Importantly, neither of these mRNAs were sensitive to RocA in the CT lysate, consistent with previous results (18) .
To assess the effect of RocA on translation pre-initiation complex formation, we used in vitro translation reactions programmed with full-length GAPDH or MYC mRNAs and inhibited the reactions with both GMPPNP and RocA. Western blots of fractionated reactions showed a further decrease in EIF4A1 recruitment in the HLH* in vitro translation extracts programmed with MYC mRNA compared to GMPPNP alone (Fig. 3 , C -E, compare to fig. S4 , A and B).
RocA did not affect EIF4A1 distributions in GAPDH-programmed reactions or in CT extracts programmed with MYC mRNA, showing that the combined defect of the HLH* EIF3A and RocA on EIF4A1 association with 48S pre-initiation complexes is also transcript-specific. No significant difference was observed for Met-tRNA i distribution, suggesting it is not perturbed by RocA ( fig. S4C ).
EIF3A HLH motif interacts with mRNAs in counterpoint to EIF4A1
In the yeast Saccharomyces cerevisiae, the EIF3A N-terminal domain (NTD), which includes the HLH motif, has been shown to enhance re-initiation upon translation of upstream open reading frames uORF1 and uORF2 of GCN4 (19) (20) (21) , likely by interacting with mRNA at the mRNA exit channel of the 40S subunit (22) . Notably, in addition to being tuned to levels of active eIF2, control of GCN4 translation by the uORFs in its 5'-UTR also requires scanning in an eIF4A-dependent manner (23) . Translational control of the functional ortholog of Gcn4 in mammals -stress response transcription factor ATF4 -also requires uORFs (24) . Briefly, after translation of ATF4 uORF1 under normal conditions, ribosomes re-initiate and continue scanning, encountering inhibitory uORF2, which causes dissociation before the start codon (24) . Under stressed conditions with low eIF2, a portion of ribosomes scans through uORF2 and initiates at the start codon. Deletion of uORF1 in the 5'-UTR lowers translation under normal conditions, while deletion of uORF2 elevates it (24) . Unlike MYC, we did not identify ATF4 as an EIF3A HLH*-sensitive mRNA ( ( Fig. 3B) . Thus, while HLH* EIF3A does not appear to affect ATF4 uORF translation appreciably ( Fig. 3F) , it can counterbalance EIF4A1 regulation of certain transcripts, as reflected in the reversal of RocA sensitivity of mRNAs harboring the ATF4 5'-UTR element.
HLH* EIF3A suppresses MYC-induced proliferation of Burkitt's lymphoma cells
MYC overexpression is responsible for the transformation of Ramos Burkitt's lymphoma cells (25) , which prompted us to assess the effect of HLH* EIF3A on proliferation of these MYCaddicted cells. We observed a substantial decrease in MYC and MET protein levels in Ramos
Burkitt's lymphoma cell lines expressing the HLH* but not CT EIF3A (Fig. 4A, fig. S6A ), more than the mean global decrease in translation in the HLH* Ramos cell lines compared to the CT control cell lines ( fig. S6B ). To assess the combined effect of HLH* EIF3A and EIF4A1
inhibition, CT and HLH* Ramos cells were cultured overnight in the presence of increasing concentrations of RocA. The HLH* Ramos cells were much more sensitive to RocA compared to CT cells (Fig. 4C) . This is consistent with the synergistic sensitization of MYC 5'-UTR observed in in vitro translation extracts ( Fig. 3B) , and given Ramos cell addiction to MYC overexpression (25) . The sensitization effect of HLH* also occurred in the presence of chemotherapeutic agent doxorubicin ( Fig. 4D ).
Discussion
Mammalian eIF3 has been shown to regulate translation initiation of specific mRNAs in a variety of ways: by binding RNA secondary structures in mRNA 5'-UTRs that activate or repress translation, through EIF3D binding to the m 7 G cap, and through m 6 A-dependent interactions with specific mRNAs (3-6). Viral genomic RNAs also target eIF3 to promote translation initiation (26, 27) . Structural studies of HCV IRES binding and incorporation into translation preinitiation complexes revealed that the IRES displaces eIF3 from the 40S ribosomal subunit (12) . The HCV IRES-driven mode of interaction also requires an HLH RNA binding motif in the EIF3A subunit of eIF3 that is critical for IRES binding and function. Mutation of the putative RNA-binding loop in the HLH motif of EIF3A disrupted eIF3 binding to the IRES and also to the 40S ribosomal subunit (11) . Here, using a combination of cell engineering and ribosome profiling, we show that mutating the loop in the HLH motif of EIF3A affects the translation of a discrete set of cellular mRNAs. The set of cellular transcripts identified as functionally dependent on the EIF3A HLH motif does not overlap with the eIF3-dependent mRNAs identified previously that require RNA secondary structures (3), rely on EIF3D cap-binding (4), or m 6 A recognition (5, 6) , suggesting that the HLH motif in EIF3A contributes to translation of these mRNA using a different mechanism.
In contrast to the HCV IRES, the cellular transcripts sensitive to mutations in the HLH motif of EIF3A are not enriched for putative viral-like RNA secondary structural elements in their 5'-UTRs to which eIF3 could bind (28) , and are not enriched for uORFs (29, 30) . Since the mutation of the HLH motif in EIF3A also disrupts direct binding to the 40S ribosomal subunit (11), translation of the cellular mRNAs identified here may be those most dependent upon the interaction of eIF3 with the 40S subunit. Structural and biochemical evidence has shown eIF3 interacts with the 40S subunit at both the mRNA entry and exit sites within pre-initiation complexes (22) . Specifically, the N-terminal domain of EIF3A binds the 40S subunit at the mRNA exit site, while the C-terminal domain projects towards the mRNA entry tunnel. In yeast, mutations in the N-terminal region of eIF3a that weaken mRNA binding to 48S pre-initiation complexes sensitize these to mRNA interactions at the mRNA entry channel, remote from where eIF3a interacts with the 40S subunit. Conversely, mutations in the C-terminus of eIF3a that affect mRNA interactions with the mRNA entry channel also influence mRNA interactions with the mRNA exit site on the opposite side of the 40S subunit. These results reveal a long-distance connection between the two mRNA binding regions in the 48S pre-initiation complex important for mRNA recruitment (10) . The HLH motif in human EIF3A resides in the N-terminal region that binds at the mRNA exit site and, in yeast, is proposed to generally stabilize recruitment of mRNAs to the 43S pre-initiation complex (22) . By analogy to the yeast system, the 3-amino acid mutation in the HLH motif in human EIF3A that disrupts eIF3 interactions with the 40S subunit (11) would be predicted to globally decrease favorable interactions of PICs with cellular mRNAs in the mRNA exit channel (Fig. 5A) . Global elimination of eIF3-induced mRNA interactions at the mRNA exit site in complexes harboring HLH* EIF3A would then result in decreased translation initiation on transcripts with the least stable interactions in the mRNA entry channel (Fig. 5A) , possibly explaining the observed specificity in translation efficiency in HLH* EIF3A expressing cells.
In addition to uncovering cellular mRNAs that may be most sensitive to interactions with the 43S pre-initiation complex at the mRNA entry channel, we found that the HLH motif in EIF3A acts as a counterbalance to the action of EIF4A1 during translation initiation. The in vitro translation reactions using HLH* cell extracts demonstrated that the HLH* mutations destabilize interactions between EIF3A, the 40S subunit and EIF5B in a transcript-independent manner ( Fig. 2), as seen before using a reconstituted system (11) . We also found that the HLH mutation destabilizes interactions of initiation complexes with EIF4A1 in a transcript-specific manner, possibly due to weakening eIF3 binding to pre-initiation complexes (Fig. 2) (31) . The interaction of the HLH motif in EIF3A and EIF4A1 with the mRNA at the exit and entry points of the initiation complex, respectively, likely affects the dynamics of mRNA scanning to the start codon in a transcript-specific manner, as well as affecting mRNA recruitment (22, 31) . This transcript specificity is enhanced in the presence of RocA, which locks EIF4A1 onto poly-purine stretches in the 5'-UTR, thereby stalling scanning and mRNA unwinding (18) . In the context of an HLHsensitive transcript, RocA exacerbates the translational defect due to HLH* EIF3A (Fig. 3B) by further depleting EIF4A1 from 48S pre-initiation complexes (Fig. 2, E and F, Fig. 3 , D and E).
By contrast, for transcripts that are not highly reliant on the HLH motif in EIF3A, such as ATF4, RocA repression is alleviated by HLH* EIF3A. Taken together, these results suggest that loosening and tightening of mRNA contacts at either end of the mRNA channel in the 48S preinitiation complex can lead to combinatorial increases or decreases in translation in a transcriptspecific manner. The mRNA entry and exit channels are spatially separated (8, 10, 22) , implying that HLH* EIF3A loosening of mRNA contacts at the mRNA exit channel of the pre-initiation complex must propagate to the mRNA entry channel to affect the EIF4A1-mRNA interaction, connecting the functions of EIF3A and EIF4A1 during mRNA scanning (Fig. 5) .
To test whether the molecular insights gained using HLH* EIF3A could have physiological implications in cancer, we generated HLH* EIF3A expressing Ramos Burkitt's lymphoma cell lines, which are addicted to MYC overexpression for their proliferation (25) . We observed that HLH* EIF3A resulted in a dramatic decrease in MYC protein levels and a severe growth defect. The fact that HLH* EIF3A is sufficient to lower MYC levels in these lymphoma cells and increase their sensitivity to chemotherapeutic compounds suggests that eIF3 could serve as a potential target for future cancer therapeutic strategies. Our model for how the HLH motif in EIF3A confers specificity on the translation of specific mRNAs involved in various pathways leading to cell proliferation makes it an intriguing target for treating a wide range of cancers. For example, by combining HLH* EIF3A with RocA treatment, we envision targeting both locations of mRNA engagement with the 48S pre-initiation complex, the mRNA entry and exit channels, to achieve selective inhibition of translation. Alternatively, targeting the HLH motif in EIF3A could be used in conjunction with drugs that target completely different pathways, e. g. doxorubicin, a drug thought to target DNA topoisomerases (32) and is commonly used in the treatment of Burkitt's lymphoma. Taken together the EIF3A HLH motif is an attractive new target for drug development to be employed in combination cancer therapy approaches. 
Materials and Methods
Cell
Ribosome Profiling
Ribosome profiling libraries were prepared from three biological replicates per cell line according to previously described methods (33 
see Supplementary Methods). All data has been deposited in Gene Expression
Ombinus (accession number ___ ).
5'-UTR uORF and secondary structure computational analysis
We used the databases uORFdb (29) 
Western Blotting
The following antibodies were used for Western blot analysis using the manufacturers' suggested dilutions: anti-beta-Actin ( IgG-HRP (A00160), anti-Rabbit IgG-HRP (NA934V). Protein levels in Western blots were quantified using ImageJ (38) .
In vitro transcription
RNAs were transcribed from 1 µg of PCR-amplified templates using T7 RNA polymerase in 1x 
In vitro translation
Cell extracts were prepared from CRISPRi-engineered HEK293T cell lines at ~80% confluency. 
Sucrose gradient fractionation
In vitro translation reactions were sedimented on 10-25% sucrose gradients (containing 20 mM HEPES pH 7.5, 150 mM KOAc, 2.5 mM MgOAc, 1 mM DTT, 0.2 mM spermidine, 100 µg/mL cycloheximide if reaction contained cycloheximide) for 3.5 hrs at 240,000 g at 4 °C using a SW41 
Northern Blotting
Total RNA isolated from the sucrose gradient fractions was resolved using a 10% polyacrylamide gel in 0.5x TBE buffer buffer (1x TBE buffer contains 89 mM Tris, 89 mM boric acid, and 2 mM 
Cell viability assays
Ramos cells were seeded at 1 x 10 6 cells/mL into 96-well plates in the presence or absence of drug (RocA, gift from Nicholas Ingolia Lab, 0 -0.1 µM; Doxorubicin (Fisher BP25161), 0 -4 µM), cultured for 24 hours, and cell viability was assessed using CellTiter-Glo assay according to the manufacturer's protocol (Promega G7570).
Metabolic labeling
Cells were seeded at 1 x 10 6 cells/mL into 6-well plates and allowed to adhere and grow Highlighted in purple are transcripts with a >3x change in expression. 
Supplementary Tables
Included in a single Excel .xlsx file: Table S1 . RNAseq data (Supplementary Tables, tab 1 , "RNAseq nonzero") Table S2 . Ribosome profiling data (Supplementary Tables, tab 2 , "RP (RSnonzero match)") 
